Bank Zachodni WBK SA:戦略・SWOT・企業財務分析

◆英語タイトル:Bank Zachodni WBK SA - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA8014828
◆発行会社(調査会社):MarketLine
◆発行日:2017年11月12日
◆ページ数:40
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ポーランド
◆産業分野:金融サービス
◆販売価格オプション(消費税別)
Single UserUSD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Bank Zachodni WBK SA – Strategy, SWOT and Corporate Finance Report
Summary

Bank Zachodni WBK SA – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Bank Zachodni WBK S.A. (BZWS), a subsidiary of Banco Santander, S.A., offers personal banking, companies banking, corporation banking, VIP banking, and private banking. Personal banking comprises accounts, cards, loans, savings and investments, and insurance. Companies banking include loans, accounts, cards, foreign trade, investments, factoring, leasing, and treasury. Corporation banking contains transactional banking, trade financing, real estate financing, capital market, and leasing. VIP banking consists of wealthy customer service center, investments, insurance, cash loans, and mortgages. Private banking comprises daily finance, consultancy, financing premium, and investment advisory. It offer products and services through a network of branch offices, ATMs, and online portals to individual, corporate, SME, high net worth individual, and wealthy families across the country. BZWS is headquartered in Wroclaw, Poland.

Scope

- Detailed information on Bank Zachodni WBK SA required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Bank Zachodni WBK SA in the form of a SWOT analysis
- An in-depth view of the business model of Bank Zachodni WBK SA including a breakdown and examination of key business segments
- Intelligence on Bank Zachodni WBK SA’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Bank Zachodni WBK SA, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Bank Zachodni WBK SA and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Bank Zachodni WBK SA as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Bank Zachodni WBK SA’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Bank Zachodni WBK SA: Company Overview
Bank Zachodni WBK SA: Overview and Key Facts
Bank Zachodni WBK SA: Overview
Bank Zachodni WBK SA: Key Facts
Bank Zachodni WBK SA: Key Employees
Bank Zachodni WBK SA: Key Employee Biographies
Bank Zachodni WBK SA: Major Products and Services
Bank Zachodni WBK SA: Company History
Bank Zachodni WBK SA: Management Statement
Bank Zachodni WBK SA: Locations and Subsidiaries
Bank Zachodni WBK SA: Key Competitors
Bank Zachodni WBK SA: Company Analysis
Bank Zachodni WBK SA: Business Description
Bank Zachodni WBK SA: SWOT Analysis
Bank Zachodni WBK SA: SWOT Overview
Bank Zachodni WBK SA: Strengths
Bank Zachodni WBK SA: Weaknesses
Bank Zachodni WBK SA: Opportunities
Bank Zachodni WBK SA: Threats
Bank Zachodni WBK SA: Corporate Financial Deals Activity
Bank Zachodni WBK SA: Financial Deals Overview
Bank Zachodni WBK SA: Top Deals 2013 – 2017YTD*
Bank Zachodni WBK SA: Advisors
Bank Zachodni WBK SA: Top Financial Advisors
Bank Zachodni WBK SA: Capital Raising
Bank Zachodni WBK SA: Recent Developments
Bank Zachodni WBK SA: News and Events Summary
Bank Zachodni WBK SA: Business Expansion
Bank Zachodni WBK SA: Contracts
Bank Zachodni WBK SA: Corporate Governance
Bank Zachodni WBK SA: Financial Deals
Bank Zachodni WBK SA: Financial Performance
Bank Zachodni WBK SA: Grants
Bank Zachodni WBK SA: Strategy and Operations
Appendix
Contact Us
Methodology
Definitions
About MarketLine

List of Tables
Table 1: Bank Zachodni WBK SA: Key Facts
Table 2: Bank Zachodni WBK SA: Key Employees
Table 3: Bank Zachodni WBK SA: Locations and Subsidiaries
Table 4: Bank Zachodni WBK SA: Key Competitors
Table 5: Bank Zachodni WBK SA: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Bank Zachodni WBK SA: Deal Activity by Deal Type - Volume (2013 - YTD*2017)
Table 7: Bank Zachodni WBK SA: Top Deals 2013 - 2017YTD*
Table 8: Bank Zachodni WBK SA: Financial Advisor Ranking by Value (US$m)
Table 9: Bank Zachodni WBK SA: Capital Raising Volume and Value Trend (2013 - YTD*2017)
Table 10: Bank Zachodni WBK SA: Capital Raising by Deal Type (2013 - YTD*2017)
Table 11: Bank Zachodni WBK SA: News and Events Summary
Table 12: Bank Zachodni WBK SA: Business Expansion
Table 13: Bank Zachodni WBK SA: Contracts
Table 14: Bank Zachodni WBK SA: Corporate Governance
Table 15: Bank Zachodni WBK SA: Financial Deals
Table 16: Bank Zachodni WBK SA: Financial Performance
Table 17: Bank Zachodni WBK SA: Grants
Table 18: Bank Zachodni WBK SA: Strategy and Operations

★海外企業調査レポート[Bank Zachodni WBK SA:戦略・SWOT・企業財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • ProQR Therapeutics NV (PRQR):製薬・医療:M&Aディール及び事業提携情報
    Summary ProQR Therapeutics NV (ProQR) is a clinical-stage biotech company that discovers and develops drugs for the treatment of genetic disorders. The company’s lead product candidate includes QR-010, a RNA-based oligonucleotide used for the treatment of cystic fibrosis; QR-110, an oligonucleotide …
  • Honeywell International Inc (HON):企業の財務・戦略的SWOT分析
    Honeywell International Inc (HON) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Bank of Panhsin:企業の戦略・SWOT・財務情報
    Bank of Panhsin - Strategy, SWOT and Corporate Finance Report Summary Bank of Panhsin - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Pantheon Resources plc (PANR):企業の財務・戦略的SWOT分析
    Summary Pantheon Resources Plc (Pantheon Resources) is an oil and gas exploration and production company. It explores, develops and produces crude oil and natural gas resource properties. The company invests in oil and gas exploration and development. It operates hydrocarbon producing basins onshore …
  • Verbund AG:企業の発電所・SWOT分析2018
    Verbund AG - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executi …
  • Bankers Petroleum Ltd:企業の戦略的SWOT分析
    Bankers Petroleum Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Alvogen Inc-製薬・医療分野:企業M&A・提携分析
    Summary Alvogen Inc (Alvogen) develops, manufactures and markets biosimilar products, generic pharmaceuticals and OTC products. The company’s product portfolio comprises generic medications in various therapeutic areas that include oncology, cardiology, respiratory, neurology and gastroenterology. A …
  • Nokia Corp (NOKIA):企業の財務・戦略的SWOT分析
    Nokia Corp (NOKIA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Bellerophon Therapeutics Inc (BLPH):医療機器:M&Aディール及び事業提携情報
    Summary Bellerophon Therapeutics Inc (Bellerophon Therapeutics), formerly Bellerophon Therapeutics LLC is a clinical-stage biotherapeutics company that focuses on the development of therapies for the treatment of cardiopulmonary diseases. The company’s lead investigational cardiopulmonary product ca …
  • ACUTRONIC USA, Inc.:企業の戦略・SWOT・財務情報
    ACUTRONIC USA, Inc. - Strategy, SWOT and Corporate Finance Report Summary ACUTRONIC USA, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Aeterna Zentaris Inc (AEZS):製薬・医療:M&Aディール及び事業提携情報
    Summary Aeterna Zentaris Inc (Aeterna Zentaris) is a specialty biopharmaceutical company that focuses on the development and commercialization of novel pharmaceutical therapies for the treatment of endocrine disorders. The company’s lead product, macimorelin, a ghrelin receptor agonist and orally-ac …
  • Mid-America Apartment Communities Inc (MAA):企業の財務・戦略的SWOT分析
    Summary Mid-America Apartment Communities, Inc. (MAA) is a real estate investment company that operates apartment homes. The company is engaged in property development, property management, redevelopment, acquisition, sales, marketing and financing. MAA provides web-based and technology driven suppo …
  • Proteus Digital Health Inc:医療機器:M&Aディール及び事業提携情報
    Summary Proteus Digital Health Inc (Proteus) is a digital medicine company that develops and sells medicines for chronic diseases through in-house research and through partnership with the pharmaceutical, medical device and biotechnology companies. Its flagship product, Proteus Discover digital medi …
  • Autolus Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Autolus Ltd (Autolus) is a biopharmaceutical company that develops anticancer therapies. The company uses T-cell programming and manufacturing technology to develop and commercialize T-cell therapies for cancer treatment. It uses chimeric antigen receptors (CARs) or T-cell receptors (TCRs) t …
  • Rangeland Energy LLC:石油・ガス:M&Aディール及び事業提携情報
    Summary Rangeland Energy LLC (Rangeland Energy) is a midstream energy company. The company services include transloading, storing frac sand, moving inbound and outbound crude oil and associated natural gas products. It also provides Rangeland integrated oil systems, which is a multipart crude and sa …
  • Alsea SAB de CV:企業の戦略・SWOT・財務情報
    Alsea SAB de CV - Strategy, SWOT and Corporate Finance Report Summary Alsea SAB de CV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • ImmunoGen Inc (IMGN):企業の財務・戦略的SWOT分析
    ImmunoGen Inc (IMGN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • The GPT Group (GPT):企業の財務・戦略的SWOT分析
    The GPT Group (GPT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Apoteket AB:企業の戦略的SWOT分析
    Apoteket AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Pharming Group NV (PHARM):製薬・医療:M&Aディール及び事業提携情報
    Summary Pharming Group NV (Pharming) is a specialty pharmaceutical company which develops nutritional products for the treatment of genetic diseases and unmet medical needs. The company’s flagship product, Ruconest (Rhucin in non-European territories) is a recombinant human C1 inhibitor approved for …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆